Trial intelligence / Profile preview

Integrated traditional Chinese medicine granules plus adefovir for chronic hepatitis B

ChiCTR-TRC-11001263Phase 4Completed

Sponsor
Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
Start
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of adefovir dipivoxil, Tiaogan Jianpi Hexue, Tiaogan Jiedu Huashi in Chronic Hepatitis B (CHB), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Started Oct 2009; status: completed.

02

Drugs

adefovir dipivoxilTiaogan Jianpi HexueTiaogan Jiedu Huashi
03

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on ChiCTR-TRC-11001263.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-11001263.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call